The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 27, 2018
Filed:
Apr. 01, 2015
Applicant:
Bristol-myers Squibb Company, Princeton, NJ (US);
Inventors:
Guanglin Luo, Madison, CT (US);
Ling Chen, Doylestown, PA (US);
Carolyn Diane Dzierba, Middletown, CT (US);
Jonathan L. Ditta, Meriden, CT (US);
John E. Macor, Washington Crossing, PA (US);
Joanne J. Bronson, Durham, CT (US);
Assignee:
Bristol-Myers Squibb Company, Princeton, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/14 (2006.01); C07D 237/08 (2006.01); C07D 239/26 (2006.01); C07D 213/34 (2006.01); A61K 31/50 (2006.01); A61K 31/51 (2006.01); A61K 31/505 (2006.01); A61K 31/506 (2006.01); A61K 31/44 (2006.01); C07D 471/04 (2006.01); C07D 213/75 (2006.01); C07D 213/73 (2006.01); C07D 413/10 (2006.01); C07D 213/57 (2006.01); C07D 213/64 (2006.01); C07D 213/30 (2006.01); C07D 213/61 (2006.01); C07D 215/14 (2006.01); C07D 213/80 (2006.01); C07D 309/22 (2006.01); C07C 233/25 (2006.01); A61K 31/4427 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/50 (2013.01); C07C 233/25 (2013.01); C07D 213/30 (2013.01); C07D 213/34 (2013.01); C07D 213/57 (2013.01); C07D 213/61 (2013.01); C07D 213/64 (2013.01); C07D 213/73 (2013.01); C07D 213/75 (2013.01); C07D 213/80 (2013.01); C07D 215/14 (2013.01); C07D 237/08 (2013.01); C07D 239/26 (2013.01); C07D 309/22 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 413/10 (2013.01);
Abstract
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.